SCHEMBL7754976

SCHEMBL7754976

CCOC(=O)N=C(NC(=O)OCc1ccccc1)SC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 3/20 0.45
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
ATM Q13315 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
HSD17B10 Q99714 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7761445 1.00 RAB9A (0.46) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL858791 0.93 ALDH1A1 (0.49) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL858792 0.93 ALDH1A1 (0.49) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL13533438 0.93 ALDH1A1 (0.49) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL7758925 0.90 ALDH1A1 (0.47) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL7758927 0.90 ALDH1A1 (0.47) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL12217782 0.85 ALDH1A1 (0.53) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL7342215 0.85 SYK (0.46) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL7342211 0.85 SYK (0.46) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL8063409 0.84 ALDH1A1 (0.44) RAB9ANPC1ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001062242-A1 PRODRUGS OF SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2001-08-30 WO disclosed